Charles Schwab Investment Management Inc. Boosts Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Charles Schwab Investment Management Inc. boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 552,975 shares of the medical research company’s stock after acquiring an additional […]
Charles Schwab Investment Management Inc. boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 552,975 shares of the medical research company’s stock after acquiring an additional […]
